Hims & Hers Health (HIMS) Free Cash Flow (2019 - 2026)
Hims & Hers Health (HIMS) posted Free Cash Flow of $59.5 million for Q1 2026, down 18.37% sequentially from $72.9 million in Q4 2025, and up 10.69% YoY from $53.8 million in Q1 2025.
Hims & Hers Health (HIMS) Free Cash Flow (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Free Cash Flow for 8 years, with the latest figure at $59.5 million in Q1 2026.
- Quarterly Free Cash Flow rose 10.69% year-over-year to $59.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $280.5 million (up 0.54% YoY) and the FY2025 annual result came in at $274.8 million, up 9.45% from the prior year.
- Free Cash Flow fell to $59.5 million in Q1 2026 per HIMS's latest filing, from $72.9 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $119.8 million in Q3 2025 and troughed at -$19.4 million in Q1 2022.
- A 5-year average of $36.2 million and a median of $25.8 million in 2024 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2022 and 2024: Free Cash Flow sank 600.47% in 2022, then surged 802.2% in 2024.
- Over 5 years, Free Cash Flow stood at -$6.7 million in 2022, then jumped by 271.11% to $11.5 million in 2023, then soared by 802.2% to $103.5 million in 2024, then decreased by 29.53% to $72.9 million in 2025, then dropped by 18.37% to $59.5 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered $59.5 million, $72.9 million, and $119.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn | -61.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -61.87 Mn |
| Jun 30, 2026 | -61.87 Mn |
| Mar 31, 2026 | 59.51 Mn |
| Mar 31, 2026 | 59.51 Mn |
| Dec 31, 2025 | 72.91 Mn |
| Dec 31, 2025 | 72.91 Mn |
| Sep 30, 2025 | 119.84 Mn |
| Sep 30, 2025 | 119.84 Mn |
| Jun 30, 2025 | 28.25 Mn |
| Jun 30, 2025 | 28.25 Mn |
| Mar 31, 2025 | 53.76 Mn |
| Mar 31, 2025 | 53.76 Mn |
| Dec 31, 2024 | 103.46 Mn |
| Dec 31, 2024 | 103.46 Mn |
| Sep 30, 2024 | 68.18 Mn |
| Sep 30, 2024 | 68.18 Mn |
| Jun 30, 2024 | 53.59 Mn |
| Jun 30, 2024 | 53.59 Mn |
| Mar 31, 2024 | 25.79 Mn |
| Mar 31, 2024 | 25.79 Mn |